Nitrogenated Derivatives Of Pancratistatin

Abstract: The present invention concerns nitrogenated derivatives of narciclasine and pancratistatin of the following general formula (I) as well as their pharmaceutically acceptable salts. The present invention also concerns the use of these compounds in cancer therapy as well as a method for their preparation..

Patent Information

Application #

Filing Date

22 February 2011

Publication Number

49/2011

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

PIERRE FABRE MEDICAMENT

45, PLACE ABEL GANCE, F-92100 BOULOGNE-BILLANCOURT, FRANCE,

Inventors

1. MARION, FREDERIC

9 RUE DES VASES, F-31000 TOULOUSE, FRANCE,

2. ANNEREAU, JEAN PHILIPPE

11 PLACE RASPAIL, F-31400 TOULOUSE, FRANCE,

3. FAHY, JACQUES

41, AVENUE DU GENERAL DE GAULLE, F-81290 LABRUGUIERE, FRANCE

Specification

Documents

Application Documents

#	Name	Date
1	1287-DELNP-2011-GPA-(29-04-2011).pdf	2011-04-29
2	1287-DELNP-2011-Correspondence Others-(29-04-2011).pdf	2011-04-29
3	1287-DELNP-2011-Form-3-(09-08-2011).pdf	2011-08-09
4	1287-DELNP-2011-Correspondence Others-(09-08-2011).pdf	2011-08-09
5	Abstract.jpg	2011-10-04
6	1287-delnp-2011-Form-5.pdf	2011-10-04
7	1287-delnp-2011-Form-3.pdf	2011-10-04
8	1287-delnp-2011-Form-2.pdf	2011-10-04
9	1287-delnp-2011-Form-1.pdf	2011-10-04
10	1287-delnp-2011-Description (Complete).pdf	2011-10-04
11	1287-delnp-2011-Correspondence-others.pdf	2011-10-04
12	1287-delnp-2011-Claims.pdf	2011-10-04
13	1287-delnp-2011-Abstract.pdf	2011-10-04
14	1287-delnp-2011-Form-18-(29-06-2012).pdf	2012-06-29
15	1287-delnp-2011-Correspondence-Ofhers-(29-06-2012).pdf	2012-06-29
16	1287-DELNP-2011_EXAMREPORT.pdf	2016-06-30
17	1287-DELNP-2011-AbandonedLetter.pdf	2017-04-01